Sunday October 22, 2017
Home Indian Diaspora Indian woman ...

Indian woman infected with a rare drug-resistant strain of TB sets off scare in US

0
20

bacteria-108895_640

New York: An Indian woman infected with a rare drug-resistant strain of tuberculosis has created a health scare in three US states and for people on her flight and is now being treated in a special isolation facility near Washington, health officials said on Tuesday.

The woman with extensively drug-resistant TB (XDR TB) travelled from India to Chicago and the Center for Disease Control and Prevention (CDC) said that as a precautionary measure it will be contacting people who may have come into contact with her on the plane.

The woman has not been identified in keeping with the patient privacy regulations.

Asked about the flight, CDC spokesperson Tom Skinner said that the information was not available. “We likely wouldn’t provide that to you even if we had it,” he added. “We are able to get flight manifest and reach those who need to be reached. If for some reason we couldn’t get flight manifest and we needed to reach people by going public with flight number we would.”

Information about where she was from India was also not available.

CDC said, “The risk of getting a contagious disease on an airplane is low but public health officials sometimes need to alert travellers who may have been exposed to a sick passenger.

The woman, who arrived at Chicago’s O’Hare airport in April, visited Missouri and Tennessee before seeking medical treatment seven weeks after coming to the US, CDC said.

CDC said it is now working with the Illinois state Department of Health to identify people she may have been in contact with.

Based on her medical history and molecular testing, she was diagnosed with XDR TB, CDC said. She was placed in respiratory isolation at a suburban Chicago hospital and later transported by air ambulance to the National Institutes of Health (NIH) Clinical Center in Maryland, near Washington.

The National Institutes of Health said patient was in a “stable condition” at NIH Clinical Center in an isolation room in the specially designed for handling patients with respiratory infections like XDR TB.

The National Institute of Allergy and Infectious Diseases (NIAID) is treating the patient under an NIH clinical protocol for treating TB, including XDR TB, NIH said.

XDR TB is a rare type of TB that is resistant to nearly all medicines used to treat the disease. Technically, the CDC describes it as “resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs, that is, amikacin, kanamycin, or capreomycin”. (IANS)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Next Story

Actress Aparna Sen to attend 8th Chicago South Asian Film Festival

0
11

Legendary Indian film actor and Padma Shri awardee Aparna Sen will be in Chicago this week. She is synonymous with bringing Bengali cinema closer to the masses not just in India but globally too finds an artistic proximity to Chicago. She says that the architecture of the city reminds her of a studio set from a movie.

Currently in the US, Sen has been having a very hectic schedule as her latest directorial venture, Sonata, is all set to be screened at film festivals in the US.

Amidst her busy schedule Aparna Sen takes out some time to talk to
Hi India! about her creative pursuits, the scope of regional Indian cinema in the US and of course about her love for museums and eateries in Chicago

“I have been to Chicago twice before this, and I’ve enjoyed the city hugely both times. I particularly like the downtown area with its interesting art deco architecture, its museums and eateries.” – Aparna Sen

Sen who has also directed critically acclaimed films such as 36 Chowringee Lane, that won her Best Director Award at the Indian National Film Awards is looking forward to the screening of her recent directorial film Sonata in America

Aparna Sen will be in the city to attend the 8th edition of Chicago South Asian Film Festival and is appreciative of the interest alternate Indian films have been creating in the US.

(IANS)

Next Story

India Progressing Better than US, China in Digital Healthcare

0
12
Digital Healthcare
Digital Healthcare in India. Pixabay

New Delhi, Sep 22, 2017: India has progressed better than US and China in terms of its specialist doctors adopting digital modes to interact with patients and prescribe medicines, a study revealed on Friday.

According to the study, gap in US between the face-to-face medicines and medical representatives triggered mails narrowed down from 15 per cent in 2015 to 12 per cent in 2017. The study stated that digital channels are slowly but surely gaining ground over traditional ones. This year, the gap further narrowed to around 12 per cent.

 “India witnessed the narrowing of the gap between face-to-face tablet and medical representatives triggered mail from 34 per cent in 2015 to 8 per cent in 2017,” said the study conducted by Indegene — a company offering research and development solutions to healthcare and pharmaceutical enterprises.

The highest number of specialist who have adopted digital platform to deal with patients are Cardiologists, General Surgeons, Pulmonologists, Endocrinologists, and Oncologists.

(IANS)

Next Story

Integrate National Plans to Eliminate TB by 2030: WHO

The WHO South East Asia Region includes India, Bangladesh, Bhutan, North Korea, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand and Timor-Leste

0
40
India TB Outreach Work
A TB patient hopeful of being cured in India. Wikimedia

New Delhi, Sep 11, 2017: The World Health Organisation (WHO) has told the South East Asian countries to integrate their national plans and mobilise and utilise resources efficiently to reach the Tuberculosis elimination target of 2030, a statement said on Sunday.

The WHO South East Asia Region includes India, Bangladesh, Bhutan, North Korea, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand and Timor-Leste.

Also Read: Malnutrition makes children susceptible to Tuberculosis: Experts 

The global health body said that there is a need for countries to identify the package of interventions best suited to their challenges — whether that means focusing on strengthening TB services, accelerating case detection or investing in research and development.

“All countries face unique challenges, meaning they should each adapt the regional and global strategies to their context,” said a statement issued by the WHO’s South East Asia Region Office.

“We must avoid taking one-size-fits-all approach, and must instead seek out and embrace tailored solutions that meet specific needs and challenges.”

The five-day 70th Regional Committee Session of WHO South East Asia Region concluded in Male on Sunday.

According to the global health body, by planning effectively and making smart, high-impact interventions, countries across the Southeast Asia Region can lift TB’s significant burden and end the disease as a public health threat once and for all.

Although the region accounts for approximately one quarter of the world’s population, it has nearly half the number of new TB cases and close to 40 per cent of TB deaths globally.

In recognition of TB’s outsized burden, accelerating progress towards the 2030 target — which requires a 90 per cent reduction in TB deaths and 80 per cent decrease in TB incidence — is now one of WHO South-East Asia Region’s flagship priority areas of work. (IANS)